Nashville Biosciences
Curt Allen has a strong background in sales and business development. Curt is currently the Director of Sales, Imaging at Nashville Biosciences, a position they have held since September 2022. Prior to this, Curt was the Director of International Sales & Business Development at Subtle Medical from May 2021 to September 2022. Curt also served as the North America MRI Sales Manager at Esaote North America from April 2019 to May 2021. Before that, Curt worked at GE Healthcare as the MR Region Modality Leader from April 2013 to April 2019. Curt has experience in sales management and leadership roles, having served as the Regional Sales Director at Shared Imaging, LLC from March 2012 to March 2013, and at St. Jude Medical Neuromodulation from August 2010 to November 2011. Curt began their career as the Regional Sales Manager at Omnicell from January 2008 to August 2010.
Curt Allen completed their Bachelor of Science (BSc) degree at The University of Southern Mississippi in 1992. Later, they pursued an MBA degree at Southeastern Louisiana University, which they completed in 2011.
This person is not in any offices
Nashville Biosciences
Nashville Biosciences, a wholly owned subsidiary of Vanderbilt University Medical Center, was created to harness the medical center's extensive genomic and bioinformatics resources for drug and diagnostics discovery and development. Leveraging Vanderbilt University Innovation™, Nashville Biosciences serves as a commercial interface between outside companies and the formidable research capabilities housed within Vanderbilt University Medical Center, including BioVU®, one of the world’s most comprehensive genetic databases linked to de-identified medical records with years of longitudinal clinical data. This unique asset is one of the largest and highest quality of its kind, providing an unprecedented opportunity to guide R&D activity in biotech, pharma, diagnostics, medical devices and other life sciences applications.